H.R. 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Session
119th Congress Current
Status Pending
Referred to the House Committee on Energy and Commerce.Sponsors (2)
KMKevin Mullin
Democrat · Primary
Legislative Votes
No votes have been held on this legislation yet.